Gardner M J, Doolan D L, Hedstrom R C, Wang R, Sedegah M, Gramzinski R A, Aguiar J C, Wang H, Margalith M, Hobart P, Hoffman S L
School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
J Pharm Sci. 1996 Dec;85(12):1294-300. doi: 10.1021/js960147h.
Since the first demonstration of the technology a few years ago, DNA vaccines have emerged as a promising method of vaccination. In a variety of experimental systems, DNA vaccines have been shown not only to induce potent immune responses, but also to offer many advantages in terms of ease of construction, testing, and production. In this article we summarize the progress achieved in development of DNA vaccines that can protect mice from infection by the rodent malaria parasite Plasmodium yoelii, describe initial studies of immunogenicity of a malaria DNA vaccine in a primate model, and outline the strategies being employed to design the next generation of malaria DNA vaccines.
自几年前首次展示这项技术以来,DNA疫苗已成为一种很有前景的疫苗接种方法。在各种实验系统中,DNA疫苗不仅已被证明能诱导强烈的免疫反应,而且在构建、测试和生产的简易性方面也具有许多优势。在本文中,我们总结了在开发能保护小鼠免受啮齿类疟原虫约氏疟原虫感染的DNA疫苗方面所取得的进展,描述了一种疟疾DNA疫苗在灵长类动物模型中的免疫原性初步研究,并概述了为设计下一代疟疾DNA疫苗所采用的策略。